This information is accurate as of 04/6/2026. Please refer back to the website to ensure all reference information is current and up-to-date.

Victorian Department of Health: Nurse immunisers, pharmacist immunisers and ATSIHP immunisers approved to administer Arexvy

April 11, 2024
|In Show all, External News
|By Alice Black

In Victoria, nurse immunisers, pharmacist immunisers and Aboriginal and Torres Strait Islander health practitioner (ATSIHP) immunisers are authorised to administer the respiratory syncytial virus (RSV) vaccine Arexvy.

RSV is a virus that causes both upper and lower respiratory tract infections. Arexvy is used to prevent RSV in people aged 60 years and older, and is recommended for:

  • All adults aged 75 years and older
  • First Nations adults aged 60 years and older
  • adults aged 60 to 74 years with certain medical conditions.

Read more about Arexvy and RSV on our RSV reference page.

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

About MVEC

The Melbourne Vaccine Education Centre (MVEC) is an educational website, developed with the aim of providing up-to-date immunisation information for both healthcare professionals and members of the public. We are based at Murdoch Children’s Research Institute (MCRI), a research organisation, and are affiliated with SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), the Victorian Vaccine Safety Service.

Latest news

June 4, 2026

NIP: Adult pneumococcal vaccination – Program advice for health professionals
June 4, 2026

Immunisation Coalition: Vale: Prof Allan Cripps memorial tribute webinar on pneumococcal disease
Share This